✦ LIBER ✦

Rofecoxib in the Prevention of Perimenstrual Migraine: An Open-Label Pilot Trial

✍ Scribed by Randal L. Von Seggern; Lisa K. Mannix; James U. Adelman

Book ID: 109098799
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 66 KB
Volume: 44
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2004.04033.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dihydroergotamine for Early and Late Tre

Dihydroergotamine for Early and Late Treatment of Migraine With Cutaneous Allodynia: An Open-Label Pilot Trial

✍ Stephen D. Silberstein; William B. Young; Mary M. Hopkins; Cheryl Gebeline-Myers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 816 KB

An open-label pilot study on the efficac

An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine

✍ Virgilio Gallai; Andrea Alberti; Cristiana Rossi; Francesca Coppola; Beatrice Ga 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 92 KB

Metformin in the treatment of non-alcoho

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

✍ S. Nair; A. M. Diehl; M. Wiseman; G. H. Farr Jr; R. P. Perrillo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Rituximab in the treatment of dermatomyo

Rituximab in the treatment of dermatomyositis: An open-label pilot study

✍ Todd D. Levine 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Olanzapine in the treatment of anorexia

Olanzapine in the treatment of anorexia nervosa: An open label trial

✍ Powers, Pauline S. ;Santana, Carlos A. ;Bannon, Yvonne S. 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 76 KB 👁 2 views

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal